BioNano Genomics Inc vs DuPont de Nemours Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while DuPont de Nemours Inc trades at $144.26 (market cap $19.51B). The key difference: DuPont de Nemours Inc is far larger — about 1428.3× BioNano Genomics Inc's market cap, and DuPont de Nemours Inc pays a 1.66% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | DD | |
|---|---|---|
Market Cap | $13.66M | $19.51B |
Sector | Health | Basic Materials |
52-Week High | $4.92 | $154.59 |
52-Week Low | $1.06 | $90.24 |
Enterprise Value | $16.26M | $20.90B |
Dividend Yield | — | 1.66% |
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →